Who owns Tenaya Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of TNYA from SEC Form 13F filings across 103 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 103 institutions disclosed 54.1M shares of Tenaya Therapeutics, Inc. worth $37.7M — about 24.9% of shares outstanding; the largest disclosed holder is VANGUARD CAPITAL MANAGEMENT LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
103
13F holders
$37.7M
value, 2026 filers
24.9%
of shares outstanding (54.1M sh)
21
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of TNYA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 7.1M | $5.2M | 0.0% | 3.3% | -16.3% |
| 2 | MILLENNIUM MANAGEMENT LLC | 6.4M | $4.8M | 0.0% | 3% | +17.8% |
| 3 | CITADEL ADVISORS LLC | 4.6M | $3.4M | 0.0% | 2.1% | +8.7% |
| 4 | RENAISSANCE TECHNOLOGIES LLC | 4.3M | $3.2M | 0.0% | 2% | +15.3% |
| 5 | BlackRock, Inc. | 4.0M | $3.0M | 0.0% | 1.8% | +8.2% |
| 6 | Empery Asset Management, LP | 3.9M | $2.9M | 3.3% | 1.8% | -9.9% |
| 7 | MARSHALL WACE, LLP | 3.5M | $2.6M | 0.0% | 1.6% | +29.5% |
| 8 | GSA CAPITAL PARTNERS LLP | 2.7M | $1,973 | 0.1% | 1.2% | +148.8% |
| 9 | Burkehill Global Management, LP | 2.0M | $1.5M | 0.1% | 0.9% | 0.0% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 1.8M | $1.4M | 0.0% | 0.8% | +17.6% |
| 11 | ADAR1 Capital Management, LLC | 1.6M | $1.1M | 0.1% | 0.7% | +3.2% |
| 12 | Raiffeisen Bank International AG | 1.2M | $881,880 | 0.0% | 0.6% | +20.0% |
| 13 | Euclidean Capital LLC | 1.0M | $750,708 | 0.2% | 0.5% | 0.0% |
| 14 | VANGUARD FIDUCIARY TRUST CO | 987,505 | $729,766 | 0.0% | 0.5% | -2.8% |
| 15 | Mirador Capital Partners LP | 905,097 | $668,957 | 0.1% | 0.4% | +2.0% |
| 16 | STATE STREET CORP | 708,721 | $523,816 | 0.0% | 0.3% | 0.0% |
| 17 | Squarepoint Ops LLC | 659,247 | $487,249 | 0.0% | 0.3% | +89.3% |
| 18 | StepStone Group LP | 462,163 | $341,538 | 0.0% | 0.2% | 0.0% |
| 19 | UBS Group AG | 456,555 | $337,394 | 0.0% | 0.2% | -31.4% |
| 20 | JANE STREET GROUP, LLC | 450,435 | $332,917 | 0.0% | 0.2% | -61.8% |
| 21 | TWO SIGMA INVESTMENTS, LP | 380,790 | $281,442 | 0.0% | 0.2% | -70.3% |
| 22 | Casdin Capital, LLC | 361,969 | $267,531 | 0.0% | 0.2% | 0.0% |
| 23 | Invesco Ltd. | 354,862 | $262,279 | 0.0% | 0.2% | +157.1% |
| 24 | Stonepine Capital Management, LLCNEW | 352,001 | $107,429 | 0.1% | 0.2% | new |
| 25 | NORTHERN TRUST CORP | 346,371 | $256,003 | 0.0% | 0.2% | +11.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.